Topics

Centers for Disease Control

Drug-resistant staph infections MRSA
May 15 | Jeff Lagasse
Surprise: Drug-resistant staph infections cost the same or slightly less to treat than non-resistant infections, study shows.
IV dose opioids
May 15 | Beth Jones Sanborn
A new study by Yale researchers published in JAMA indicates IV dosing could be more addictive but a…
May 10 | Susan Morse
Health and Human Services Secretary Alex Azar's proposal would cut funding to the CDC and NIH, focus on opioid epidemic…
Apr 30 | Susan Morse
Providers that earn CDC-certification for type 2 diabetes prevention can earn…
New Hampshire hospitals commit $50 million to drug treatment
Apr 10 | Beth Jones Sanborn
Some of the funding will go toward opioid addiction treatment and prevention, New Hampshire Hospital Association says.
Humana improves members' 'healthy days'
Apr 04 | Susan Morse
Humana is challenged to improve the health of its Medicare Advantage population but got a boost in…
House passes funding bill
Mar 22 | Susan Morse
Insurers get no federal funds for cost-sharing reduction payments or a reinsurance program to help stabilize…
Health subcommittee to take up legislation to combat opioid epidemic
Feb 26 | Susan Morse
Three upcoming hearings will focus on controlling opioid misuse, public health and…
Why testing all adults for Hepatitis C is cost-effective
Feb 22 | Jeff Lagasse
Researchers at Boston Medical, Mass General and Stanford said screening more…
Feb 09 | Beth Jones Sanborn
Why executives should be concerned enough about the threat they pose to hire an infection control officer.

Pages